Status:
COMPLETED
Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache
Lead Sponsor:
Assiut University
Conditions:
Postdural Puncture Headache
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
In our study, we will compare a new route of nebulization for effectiveness between dexmedetomidine, neostigmine/atropine and saline placebo for females complained of postdural puncture headache (PDPH...
Detailed Description
A written informed consent will be taken from the patients. The study will involve female adults (age 18-40years) of American society of anesthesiologists (ASA) I-II who are listed for elective cesare...
Eligibility Criteria
Inclusion
- \- Clinical diagnosis of postdural puncture headache (PDPH) after elective cesarean section under spinal anesthesia.
Exclusion
- Hypersensitivity of dexmedetomidine, neostigmine or atropine
- Overactive thyroid gland
- Myasthenia gravis
- Closed angle glaucoma
- High blood pressure and coronary artery disease.
- withdrawal of consent
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04910477
Start Date
June 1 2021
End Date
September 3 2021
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt, Assuit universi